Can a vitamin prevent hepatocellular carcinoma?

Hepatology

Volumn 25, Issue 1, 1997, Pages 249-250

  Venook, Alan P ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

POLYPRENOIC ACID;

APOPTOSIS; CANCER PREVENTION; CANCER RECURRENCE; CARCINOGENESIS; HISTOLOGY; LIVER CELL CARCINOMA; NOTE; PRIORITY JOURNAL; TUMOR DIFFERENTIATION; VACCINATION; VITAMIN INTAKE;

EID: 0031030824     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1002/hep.510250146     Document Type: Note

References (10)

1. Zhou X-D, Tank Z-Y, Yu Y-Q, Yang B-H, Lin Z-Y, Lu J-Z, Ma Z-C, et al. Long-term survivors after resection for primary liver cancer. Cancer 1989; 63:2201-2206.
2. Sherman M, Peltekian KM, Lee C. Screening for hepatocellular carcinoma in chronic carriers of hepatitis B virus: incidence and prevalence of hepatocellular carcinoma in a North American urban population. HEPATOLOGY 1995;22:432-438.
3. Colombo M, De Franchis R, Del Ninno E, Sangiovanni A, De Fazio C, Tommasini M, Donato MF, et al. Hepatocellular carcinoma in Italian patients with cirrhosis. N Engl J Med 1991;325:675-680.
4. Venook AP, Ferrell LD, Roberts JP, Emond J, Frye JW, Ring E, Ascher NL, et al. Liver transplantation for hepatocellular carcinoma: results with preoperative chemoembolization. Liver Trans Surg 1995;1:242-248.
5. Venook AP. Treatment of hepatocellular carcinoma: too many options? J Clin Oncol 1994;12:1323-1334.
6. Degos L, Dombret H, Chomienne C, Daniel M-T, Miclea J-M, Chestang C, Castaigne S, et al. All-trans-retinoic acid as a differentiating agent in the treatment of acute promyelocytic leukemia. Blood 1995;85:2643-2653.
7. Muto Y, Moriwaki H, Ninomiya M, Adachi S, Saito A, Takasaki KT, Tanaka T, et al. Prevention of second primary tumors by an acyclic retinoid, polyprenoic acid, in patients with hepatocellular carcinoma. N Engl J Med 1996;334:1561-1567.
8. Livraghi T, Bolondi L, Lazzaroni S, Marin G, Morabito A, Rapaccini G, Salmi A, et al. Percutaneous ethanol injection in the treatment of hepatocellular carcinoma in cirrhosis. Cancer 1992;69:925-929.
9. Sun ZT, Zhu Y, Stjernsward J, Hilleman M, Collins R, Zhen Y, Hsia CC, et al. Design and compliance of HBV vaccination trial on newborns to prevent hepatocellular carcinoma and 5-year results of its pilot study. Cancer Detect Prev 1991;15:313-318.
10. Nishiguchi S, Kuroki T, Nakatani S, Morimoto H, Takeda T, Nakajima S, Shiomi S, et al. Randomized trial of effects of interferon-α on incidence of hepatocellular carcinoma in chronic active hepatitis C with cirrhosis. Lancet 1995;346:1051-1055.